BrainStorm Cell Therapeutics
BCLI
#9833
Rank
S$1.59 M
Marketcap
$0.30
Share price
3.51%
Change (1 day)
9.79%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2023 (TTM): -$0.81

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.77. In 2022 the company made an earnings per share (EPS) of -$0.86 an increase over its 2021 EPS that were of -$0.89.

EPS history for BrainStorm Cell Therapeutics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.81-5.9%
2022-$0.86-2.94%
2021-$0.89-37.04%
2020-$1.411.89%
2019-$1.3851.43%
2018-$0.91159.26%
2017-$0.35-3.57%
2016-$0.36-37.78%
2015-$0.59-33.82%
2014-$0.8936%
2013-$0.6511.11%
2012-$0.5950%
2011-$0.39-50%
2010-$0.78-233.33%
2009$0.59-142.86%
2008-$1.37-65%
2007-$3.91
2005$1.29-108.03%
2004-$16.0713203.07%
2003-$0.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$5.72-844.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$7.41 864.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.22 579.66%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.04-3,228.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.11 44.07%๐Ÿ‡บ๐Ÿ‡ธ USA